Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Loes F S Kooreman"'
Autor:
Natasja Hendriks, Sjoerd H van der Burg, Ziena Abdulrahman, Noel F C C de Miranda, Edith M G van Esch, Peggy J de Vos van Steenwijk, Antonios Somarakis, Arnold J Kruse, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Loes F S Kooreman, Brigitte F M Slangen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background The complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod. On the
Externí odkaz:
https://doaj.org/article/ae2985823b1043c281f9a4695715eadb
Autor:
Alexander J. Pennings, MSc, Brecht A. van der Velden, BSc, Maximilian Kloft, MSc, Loes F. S. Kooreman, MSc, Jos M. P. Kleijnen, PhD, Stephanie O. Breukink, PhD, Geerard L. Beets, PhD, Heike I. Grabsch, PhD, Jarno Melenhorst, PhD
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 4, p e336 (2023)
Objective:. In this review, we aim to provide an overview of literature on lymph node (LN) histomorphological features and their relationship with the prognosis in colorectal cancer (CRC). Background:. Lymph nodes play a crucial role in the treatment
Externí odkaz:
https://doaj.org/article/13b2c04384a84f0a8d786c601841088f
Autor:
Kristien B. I. M. Keymeulen, Sandra M. E. Geurts, Loes F. S. Kooreman, Lucien E. M. Duijm, Sanne Engelen, Sigrid Vanwetswinkel, Ernest Luiten, Sabine Siesling, Adri C. Voogd, Vivianne C. G. Tjan-Heijnen
Publikováno v:
European Radiology, 33(3), 2209-2217. Springer, Cham
Objectives For patients with ductal carcinoma in situ (DCIS), data about the impact of breast MRI at primary diagnosis on the incidence and characteristics of contralateral breast cancers are scarce. Methods We selected all 8486 women diagnosed with
Autor:
Cynthia S. E. Hendrikse, Phyllis van der Ploeg, Nienke M. A. van de Kruis, Jody H. C. Wilting, Floor Oosterkamp, Pauline M. M. Theelen, Christianne A. R. Lok, Joanne A. de Hullu, Huberdina P. M. Smedts, M. Caroline Vos, Brenda M. Pijlman, Loes F. S. Kooreman, Johan Bulten, Marjolein H. F. M. Lentjes‐Beer, Steven L. Bosch, Anja van de Stolpe, Sandrina Lambrechts, Ruud L. M. Bekkers, Jurgen M. J. Piek
Publikováno v:
Cancer, 129(9), 1361-1371. Wiley
Cancer, 129, 9, pp. 1361-1371
Cancer, 129, 1361-1371
Cancer, 129, 9, pp. 1361-1371
Cancer, 129, 1361-1371
Contains fulltext : 291887.pdf (Publisher’s version ) (Open Access) BACKGROUND: Advanced low-grade ovarian carcinoma (LGOC) is difficult to treat. In several studies, high estrogen receptor (ER) protein expression was observed in patients with LGOC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4e78328b415fa76014a1b9e212d0c2b
https://cris.maastrichtuniversity.nl/en/publications/9e6e8598-eebd-4996-aa9c-7406328c4dbe
https://cris.maastrichtuniversity.nl/en/publications/9e6e8598-eebd-4996-aa9c-7406328c4dbe
Autor:
Albertine J. Vroom, Simone Bongarts, Marlies Y. Bongers, Loes F. S. Kooreman, Steven L. Bosch, Peggy M. A. J. Geomini, Nehalennia van Hanegem
Publikováno v:
BMC Women's Health, 23(1):46. BioMed Central Ltd
Background The aim of this study is to analyze the histopathological features of endometrial samples obtained by aspiration when performed before or after the saline contrast sonohysterography in women with postmenopausal bleeding and a thickened end
Autor:
Marissa Meegdes, Khava I. E. Ibragimova, Dorien J. A. Lobbezoo, Ingeborg J. H. Vriens, Loes F. S. Kooreman, Frans L. G. Erdkamp, M. Wouter Dercksen, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Manon J. A. E. Pepels, Linda M. H. van de Winkel, Jolien Tol, Joan B. Heijns, Agnes J. van de Wouw, Natascha A. J. B. Peters, Ananda Hochstenbach-Waelen, Marjolein L. Smidt, Sandra M. E. Geurts, Vivianne C. G. Tjan-Heijnen
Publikováno v:
Breast Cancer Research and Treatment, 192(2), 331-342. Springer, Cham
Purpose The hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) are the main parameters in guiding systemic treatment choices in breast cancer, but can change during the disease course. This study aims to evaluate the biopsy rat
Autor:
T. J. A. van Nijnatten, Kristien Keymeulen, Marjolein L. Smidt, Sabine Siesling, Loes F. S. Kooreman, R.A.W. Ploumen, S.M.J. van Kuijk
Publikováno v:
European Journal of Surgical Oncology, 48(1), 60-66. ELSEVIER SCI LTD
European journal of surgical oncology, 48(1), 60-66. Elsevier
European journal of surgical oncology, 48(1), 60-66. Elsevier
INTRODUCTION: Neoadjuvant systemic therapy (NST) is increasingly applied in breast cancer to improve surgical and oncological outcome. Approximately 21% of patients receiving NST achieve pathological complete response (pCR) of the breast. There is di
Autor:
Cornelis M. de Mooij, Thiemo J. A. van Nijnatten, Briete Goorts, Loes F. S. Kooreman, Isabel W. M. Raymakers, Silke P. L. van Meijl, Maaike de Boer, Kristien B. M. I. Keymeulen, Joachim E. Wildberger, Felix M. Mottaghy, Marc B. I. Lobbes, Marjolein L. Smidt
Publikováno v:
Cancers; Volume 15; Issue 2; Pages: 401
Cancers, 15(2):401. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 15(2):401. Multidisciplinary Digital Publishing Institute (MDPI)
Simple Summary Neoadjuvant chemo(targeted) therapy (NCT) can downstage disease burden in breast cancer, allowing less invasive surgery. The ability of sequential hybrid [18F]FDG PET/MRI to predict the final pathologic primary tumour response to NCT i
Autor:
Lilian van Wagensveld, Juliette O. A. M. van Baal, Maite Timmermans, Duco Gaillard, Lauri Borghuis, Seth B. Coffelt, Efraim H. Rosenberg, Christianne A. R. Lok, Hans W. Nijman, Loes F. S. Kooreman, Joyce Sanders, Marco de Bruijn, Lodewyk F. A. Wessels, Rianne van der Wiel, Christian Rausch, Annegien Broeks, Roy F. P. M. Kruitwagen, Maaike A. van der Aa, Gabe S. Sonke, Philip C. Schouten, Koen K. Van de Vijver, Hugo M. Horlings
Publikováno v:
Cancers, 14(23):5965. MDPI AG
Cancers, 14(23):5965. Multidisciplinary Digital Publishing Institute (MDPI)
van Wagensveld, L, van Baal, J O A M, Timmermans, M, Gaillard, D, Borghuis, L, Coffelt, S B, Rosenberg, E H, Lok, C A R, Nijman, H W, Kooreman, L F S, Sanders, J, de Bruijn, M, Wessels, L F A, van der Wiel, R, Rausch, C, Broeks, A, Kruitwagen, R F P M, van der Aa, M A, Sonke, G S, Schouten, P C, van de Vijver, K K & Horlings, H M 2022, ' Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer ', Cancers, vol. 14, no. 23, 5965 . https://doi.org/10.3390/cancers14235965
Cancers; Volume 14; Issue 23; Pages: 5965
Cancers, 14(23):5965. Multidisciplinary Digital Publishing Institute (MDPI)
van Wagensveld, L, van Baal, J O A M, Timmermans, M, Gaillard, D, Borghuis, L, Coffelt, S B, Rosenberg, E H, Lok, C A R, Nijman, H W, Kooreman, L F S, Sanders, J, de Bruijn, M, Wessels, L F A, van der Wiel, R, Rausch, C, Broeks, A, Kruitwagen, R F P M, van der Aa, M A, Sonke, G S, Schouten, P C, van de Vijver, K K & Horlings, H M 2022, ' Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer ', Cancers, vol. 14, no. 23, 5965 . https://doi.org/10.3390/cancers14235965
Cancers; Volume 14; Issue 23; Pages: 5965
How the tumor’s genetic make up (i.e. molecular profiles) is associated with changes in the tumor microenvironment (TME) in high-grade serous ovarian cancer (HGSOC) is incompletely understood, while these factors influence survival. To investigate
Autor:
Ziena Abdulrahman, Natasja Hendriks, Arnold J Kruse, Antonios Somarakis, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Noel F C C de Miranda, Loes F S Kooreman, Brigitte F M Slangen, Sjoerd H van der Burg, Peggy J de Vos van Steenwijk, Edith M G van Esch
Publikováno v:
Journal for ImmunoTherapy of Cancer, 10(11). BMJ PUBLISHING GROUP
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd.
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd.
BackgroundThe complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod. On the